Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study

Published: 3 July 2019
Author(s): Guillaume Bayer, Marie-Sara Agier, Bertrand Lioger, Marion Lepelley, Marie Zenut, Mary-Christine Lanoue, François Maillot, Annie-Pierre Jonville-Bera
Issue: July 2019
Section: Original Article

Rituximab induced serum sickness (RISS) is a rare delayed hypersensitivity reaction. The aim of this study was to describe the epidemiological and clinical characteristics of the RISS cases reported in France.